Navigation Links
China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)

BEIJING, Nov. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that it will host an earnings conference call covering its third quarter 2011 financial results on Tuesday, November 8, 2011 at 8:00 a.m. EST (New York), which is also 9:00 p.m. in China on the same day.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer of the Company, and Mr. Tristan Kuo, the Company's Chief Financial Officer.The dial-in details for the live conference call are as follows:U.S. toll-free number:

1 866 549 1292U.K. toll-free number:

0 800 279 7818Mainland China toll-free number:

800 876 8626Hong Kong local access number:

3005 2050International toll number:

+852 3005 2050Conference passcode:

674477#A telephone replay will be available after the conclusion of the conference call for thirty days, until December 7, 2011.The dial-in details for the replay are as follows:U.S. toll-free number:

1 866 753 0743U.K. toll-free number:

0 808 234 7126Mainland China number:

800 876 8594Hong Kong number:

3005 2020International toll number:

+852 3005 2020 Conference ID:

138012# About China Biologic Products, Inc.China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Co., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is one of the leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website at for additional information.

Company contact:Mr. Y. Tristan Kuo
Chief Financial Officer
China Biologic Products, Inc.
Telephone: +86 53 8620 2206


SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
2. China Biologic Named to Asias "200 Best Under a Billion" by Forbes Asia
3. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
4. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
5. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
6. Industrial Biotechnology China News 1109 - Annual Subscription
7. ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China
8. China Cord Blood Corporation Files Its Annual Report on Form 20-F
9. China Botanic Pharmaceutical Reports Third-Quarter Fiscal Year 2011 Results
10. Industrial Biotechnology China News 1108
11. China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  Culprits beware, a University ... professor Jan Halámek, is taking crime scene fingerprint ...   -->   ... --> --> Halámek ... discovered a straightforward concept for identifying whether a ...
(Date:11/30/2015)... ... November 30, 2015 , ... Imagine Exhibitions and ... The Exhibition, opening in March 2016 at Melbourne Museum in Melbourne, Australia. Immediately ... several North American tour dates. The Exhibition is based on Universal Pictures’ Jurassic ...
(Date:11/30/2015)... DIEGO , Nov. 30, 2015  HUYA Bioscience ... China,s pharmaceutical innovations, today announced it ... Drug Development Fund (KDDF) to foster collaboration between KDDF ... development and commercialization of healthcare products for the global ... as an important source of new innovative preclinical and ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
Breaking Biology News(10 mins):